glp 1 overdose GLP-1 Drug GLP-1 Overdose & Pharmaceutical Negligence

Journal of Agricultural and Food Chemistry, 67 (13), 36053614

Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone

However, they have restrictions on prescribing non-essential medications in accordance with medical regulations, and the high cost and limited accessibility of GLP-1 RAs may hinder their widespread use

Emerging multi-agonists such as retatrutide (GLP-1/GIP/glucagon triple agonist) and PTT-A (novel unimolecular peptide tetra-agonist targeting GLP-1, GIP, glucagon and amylin receptors) further expand this concept

10.1002/iub.2046 44 ZhangL.LiP.TangZ.DouQ.FengB

[DOI] [PubMed] [Google Scholar] 31.Naessen S., Carlstrm K., Holst J.J., Hellstrm P.M., Hirschberg A.L